BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 23012118)

  • 21. Cost-effectiveness modeling of colorectal cancer: computed tomography colonography vs colonoscopy or fecal occult blood tests.
    Lucidarme O; Cadi M; Berger G; Taieb J; Poynard T; Grenier P; Beresniak A
    Eur J Radiol; 2012 Jul; 81(7):1413-9. PubMed ID: 21444171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Colon cancer screening and surveillance controversies.
    Lieberman D
    Curr Opin Gastroenterol; 2009 Sep; 25(5):422-7. PubMed ID: 19465849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New European initiatives in colorectal cancer screening: Budapest Declaration. Official appeal during the Hungarian Presidency of the Council of the European Union under the Auspices of the United European Gastroenterology Federation, the European Association for Gastroenterology and Endoscopy and the Hungarian Society of Gastroenterology.
    Wittmann T; Stockbrugger R; Herszényi L; Jonkers D; Molnár B; Saurin JC; Regula J; Malesci A; Laghi L; Pintér T; Teleky B; Dítě P; Tulassay Z
    Dig Dis; 2012; 30(3):320-2. PubMed ID: 22722559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-effectiveness of colorectal cancer screening - an overview.
    Lansdorp-Vogelaar I; Knudsen AB; Brenner H
    Best Pract Res Clin Gastroenterol; 2010 Aug; 24(4):439-49. PubMed ID: 20833348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Colorectal cancer screening: practice guidelines.
    Lieberman D
    Dig Dis; 2012; 30 Suppl 2():34-8. PubMed ID: 23207930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Taishotoyama Symposium Barriers to colorectal cancer screening: economics, capacity and adherence.
    Inadomi JM
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S198-204. PubMed ID: 19120898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening for colorectal cancer.
    Saliangas K
    Tech Coloproctol; 2004 Nov; 8 Suppl 1():s10-3. PubMed ID: 15655587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Delivering colonoscopy screening for low-income populations in Suffolk County: strategies, outcomes, and benchmarks.
    Lane DS; Messina CR; Cavanagh MF; Anderson JC
    Cancer; 2013 Aug; 119 Suppl 15():2842-8. PubMed ID: 23868478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quality assurance in colonoscopy for colorectal cancer diagnosis.
    Macken E; Moreels T; Vannoote J; Siersema PD; Van Cutsem E
    Eur J Surg Oncol; 2011 Jan; 37(1):10-5. PubMed ID: 20951537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk for colorectal cancer in elderly persons and possible methodologies for their screening.
    Rozen P; Shabtai EI; Liphshitz I; Barchana M
    Eur J Gastroenterol Hepatol; 2011 May; 23(5):431-7. PubMed ID: 21448071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of the rising colorectal cancer incidence in young adults on the optimal age to start screening: Microsimulation analysis I to inform the American Cancer Society colorectal cancer screening guideline.
    Peterse EFP; Meester RGS; Siegel RL; Chen JC; Dwyer A; Ahnen DJ; Smith RA; Zauber AG; Lansdorp-Vogelaar I
    Cancer; 2018 Jul; 124(14):2964-2973. PubMed ID: 29846933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical case management and navigation for colonoscopy screening in an academic medical center.
    Cavanagh MF; Lane DS; Messina CR; Anderson JC
    Cancer; 2013 Aug; 119 Suppl 15():2894-904. PubMed ID: 23868484
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.
    Tsoi KK; Ng SS; Leung MC; Sung JJ
    Aliment Pharmacol Ther; 2008 Aug; 28(3):353-63. PubMed ID: 18638075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness of capsule endoscopy in screening for colorectal cancer.
    Hassan C; Zullo A; Winn S; Morini S
    Endoscopy; 2008 May; 40(5):414-21. PubMed ID: 18302080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-effectiveness of colorectal cancer screening with computed tomography colonography or fecal blood tests.
    Heresbach D; Chauvin P; Grolier J; Josselin JM
    Eur J Gastroenterol Hepatol; 2010 Nov; 22(11):1372-9. PubMed ID: 20802341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Limitations of the faecal occult blood test in screening for colorectal cancer.
    Delcò F; Sonnenberg A
    Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):119-26. PubMed ID: 10363196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent diagnostic procedures for colorectal cancer screening: Are they cost-effective?
    Arafa MA; Farhat KH
    Arab J Gastroenterol; 2017 Sep; 18(3):136-139. PubMed ID: 28988790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and programmatic costs of implementing colorectal cancer screening: evaluation of five programs.
    Subramanian S; Tangka FK; Hoover S; Degroff A; Royalty J; Seeff LC
    Eval Program Plann; 2011 May; 34(2):147-53. PubMed ID: 21036399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of efficacy and cost-effectiveness when screening colonoscopy is performed by nongastroenterologists.
    Hassan C; Rex DK; Zullo A; Cooper GS
    Cancer; 2012 Sep; 118(18):4404-11. PubMed ID: 22707430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Population-based screening for colorectal cancer: Australian research and implementation.
    Young GP
    J Gastroenterol Hepatol; 2009 Oct; 24 Suppl 3():S33-42. PubMed ID: 19799696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.